Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for +publisher:"Purdue University" +contributor:("Mohamed Seleem"). Showing records 1 – 4 of 4 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Purdue University

1. Thangamani, Shankar. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.

Degree: PhD, 2016, Purdue University

  Bacterial and fungal resistance to conventional antimicrobials is a burgeoning global health epidemic that necessitates urgent action. Even more alarming, the development of new… (more)

Subjects/Keywords: Biological sciences; Health and environmental sciences; Antimicrobial resistance; Approved drugs; Bacteria; Drug discovery; Fungi; Repurposing; Immunology and Infectious Disease; Microbiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thangamani, S. (2016). Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. (Doctoral Dissertation). Purdue University. Retrieved from https://docs.lib.purdue.edu/open_access_dissertations/1015

Chicago Manual of Style (16th Edition):

Thangamani, Shankar. “Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.” 2016. Doctoral Dissertation, Purdue University. Accessed January 24, 2020. https://docs.lib.purdue.edu/open_access_dissertations/1015.

MLA Handbook (7th Edition):

Thangamani, Shankar. “Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.” 2016. Web. 24 Jan 2020.

Vancouver:

Thangamani S. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. [Internet] [Doctoral dissertation]. Purdue University; 2016. [cited 2020 Jan 24]. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1015.

Council of Science Editors:

Thangamani S. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. [Doctoral Dissertation]. Purdue University; 2016. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1015


Purdue University

2. Dabral, Neha. NOVEL STRATEGIES TO DEVELOP BETTER BRUCELLOSIS VACCINES USING BRUCELLA ABORTUS RB51 AND B. NEOTOMAE.

Degree: PhD, Comparative Pathobiology, 2014, Purdue University

 The genus Brucella consists of Gram-negative, facultative intracellular coccobacilli that can cause chronic infections in several mammals. Brucella spp. can exhibit a smooth or rough… (more)

Subjects/Keywords: Brucella; Exopolysaccharide; Gamma irradiation; Overexpression; Prime-boost; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dabral, N. (2014). NOVEL STRATEGIES TO DEVELOP BETTER BRUCELLOSIS VACCINES USING BRUCELLA ABORTUS RB51 AND B. NEOTOMAE. (Doctoral Dissertation). Purdue University. Retrieved from https://docs.lib.purdue.edu/open_access_dissertations/1071

Chicago Manual of Style (16th Edition):

Dabral, Neha. “NOVEL STRATEGIES TO DEVELOP BETTER BRUCELLOSIS VACCINES USING BRUCELLA ABORTUS RB51 AND B. NEOTOMAE.” 2014. Doctoral Dissertation, Purdue University. Accessed January 24, 2020. https://docs.lib.purdue.edu/open_access_dissertations/1071.

MLA Handbook (7th Edition):

Dabral, Neha. “NOVEL STRATEGIES TO DEVELOP BETTER BRUCELLOSIS VACCINES USING BRUCELLA ABORTUS RB51 AND B. NEOTOMAE.” 2014. Web. 24 Jan 2020.

Vancouver:

Dabral N. NOVEL STRATEGIES TO DEVELOP BETTER BRUCELLOSIS VACCINES USING BRUCELLA ABORTUS RB51 AND B. NEOTOMAE. [Internet] [Doctoral dissertation]. Purdue University; 2014. [cited 2020 Jan 24]. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1071.

Council of Science Editors:

Dabral N. NOVEL STRATEGIES TO DEVELOP BETTER BRUCELLOSIS VACCINES USING BRUCELLA ABORTUS RB51 AND B. NEOTOMAE. [Doctoral Dissertation]. Purdue University; 2014. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1071


Purdue University

3. Mohamed, Mohamed F. TARGETING MULTI-DRUG RESISTANT PATHOGENS WITH NOVEL ANTIMICROBIAL PEPTIDES.

Degree: PhD, Comparative Pathobiology, 2016, Purdue University

 The emergence of antibiotic resistance is a notorious problem worldwide. In the United States alone, antibiotic-resistant bacteria infect at least two million people and kill… (more)

Subjects/Keywords: antibiotic resistance; antiinflammatory; Antimicrobial peptides; biofilm; MRSA; pseudomonas

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mohamed, M. F. (2016). TARGETING MULTI-DRUG RESISTANT PATHOGENS WITH NOVEL ANTIMICROBIAL PEPTIDES. (Doctoral Dissertation). Purdue University. Retrieved from https://docs.lib.purdue.edu/open_access_dissertations/1223

Chicago Manual of Style (16th Edition):

Mohamed, Mohamed F. “TARGETING MULTI-DRUG RESISTANT PATHOGENS WITH NOVEL ANTIMICROBIAL PEPTIDES.” 2016. Doctoral Dissertation, Purdue University. Accessed January 24, 2020. https://docs.lib.purdue.edu/open_access_dissertations/1223.

MLA Handbook (7th Edition):

Mohamed, Mohamed F. “TARGETING MULTI-DRUG RESISTANT PATHOGENS WITH NOVEL ANTIMICROBIAL PEPTIDES.” 2016. Web. 24 Jan 2020.

Vancouver:

Mohamed MF. TARGETING MULTI-DRUG RESISTANT PATHOGENS WITH NOVEL ANTIMICROBIAL PEPTIDES. [Internet] [Doctoral dissertation]. Purdue University; 2016. [cited 2020 Jan 24]. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1223.

Council of Science Editors:

Mohamed MF. TARGETING MULTI-DRUG RESISTANT PATHOGENS WITH NOVEL ANTIMICROBIAL PEPTIDES. [Doctoral Dissertation]. Purdue University; 2016. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1223


Purdue University

4. Ahmed, Sara. Drug Delivery to Solid Tumors via Polymeric Nanoparticles.

Degree: PhD, Industrial and Physical Pharmacy, 2015, Purdue University

 A main challenge in chemotherapy is to deliver an anti-cancer drug selectively to tumor and avoid off-target exposure to other body tissues and organs. Nanoparticles… (more)

Subjects/Keywords: Chitosan; Drug delivery; Nanoparticles; Paclitaxel; Tumors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ahmed, S. (2015). Drug Delivery to Solid Tumors via Polymeric Nanoparticles. (Doctoral Dissertation). Purdue University. Retrieved from https://docs.lib.purdue.edu/open_access_dissertations/1080

Chicago Manual of Style (16th Edition):

Ahmed, Sara. “Drug Delivery to Solid Tumors via Polymeric Nanoparticles.” 2015. Doctoral Dissertation, Purdue University. Accessed January 24, 2020. https://docs.lib.purdue.edu/open_access_dissertations/1080.

MLA Handbook (7th Edition):

Ahmed, Sara. “Drug Delivery to Solid Tumors via Polymeric Nanoparticles.” 2015. Web. 24 Jan 2020.

Vancouver:

Ahmed S. Drug Delivery to Solid Tumors via Polymeric Nanoparticles. [Internet] [Doctoral dissertation]. Purdue University; 2015. [cited 2020 Jan 24]. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1080.

Council of Science Editors:

Ahmed S. Drug Delivery to Solid Tumors via Polymeric Nanoparticles. [Doctoral Dissertation]. Purdue University; 2015. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1080

.